Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Inactivated EEE Vaccine TSI-GSD 104
NCT00584805Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Jun 2008
- Primary completion
- Jun 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of inactivated eastern equine encephalitis vaccine TSI-GSD 104 in eastern equine encephalitis (EEE), sponsored by U.S. Army Medical Research and Development Command. Primary endpoint: Subject Response Rates for PRNT80 Titers at 5 years. Started Jun 2008; status: completed.
02
Drugs
inactivated eastern equine encephalitis vaccine TSI-GSD 104
03
Conditions
eastern equine encephalitis (EEE)
Beyond the preview
Go deeper on NCT00584805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00584805.